← Eichor
Condition: Adrenal Cortex Hormones Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adrenal Cortex Hormones

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06487481A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resist
Phase 1 · 6 location(s) · Daiichi Sankyo · NCT07189403Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Phase N/A · 10 location(s) · Latin American Cooperative Oncology Group · NCT06279442An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143International Pediatric Adrenocortical Tumor Registry
Phase N/A · 5 location(s) · St. Jude Children's Research Hospital · NCT00700414PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
Phase 2 · 4 location(s) · Maria Sklodowska-Curie National Research Institute of Oncolo · NCT05563467Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
Phase 2 · 1 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT05913427Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Canc
Phase 3 · 33 location(s) · M.D. Anderson Cancer Center · NCT03583710Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adre
Phase 2 · 1 location(s) · West China Hospital · NCT04318730Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07335679Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT04897321Adrenal Tumors - Pathogenesis and Therapy
Phase N/A · 1 location(s) · University of Wuerzburg · NCT00669266Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
NA · 1 location(s) · Haukeland University Hospital · NCT05368090Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
NA · 1 location(s) · University Hospital, Toulouse · NCT07470580Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Phase 2 · 22 location(s) · UNICANCER · NCT06333314Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid
Phase 1 · 3 location(s) · Anusha Kalbasi · NCT04119024Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06066333Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer
Phase 2 · 1 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT07085572A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06041516German Adrenocortical Carcinoma Registry
Phase N/A · 1 location(s) · University of Wuerzburg · NCT00453674A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
NA · 1 location(s) · Zhe Meng · NCT06250699Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06587802Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unres
Phase 2 · 2 location(s) · Emory University · NCT06006013Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
Phase 4 · 25 location(s) · McMaster University · NCT05114096Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescent
Phase 2 · 77 location(s) · National Cancer Institute (NCI) · NCT06900595Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty
NA · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07337772
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.